These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17979653)

  • 1. Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans.
    Lennernäs H
    Curr Drug Metab; 2007 Oct; 8(7):645-57. PubMed ID: 17979653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel simulated media system for in vitro evaluation of bioequivalent intestinal drug solubility.
    Abuhassan Q; Silva MI; Tamimi RA; Khadra I; Batchelor HK; Pyper K; Halbert GW
    Eur J Pharm Biopharm; 2024 Jun; 199():114302. PubMed ID: 38657741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs.
    Zhang SY; Ong WSY; Subelzu N; Gleeson JP
    Int J Pharm; 2024 May; 656():124089. PubMed ID: 38599444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structured solubility behaviour in fed simulated intestinal fluids.
    Silva MI; Khadra I; Pyper K; Halbert GW
    Eur J Pharm Biopharm; 2023 Dec; 193():58-73. PubMed ID: 37890541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-Head Comparison of Caco-2 Transwell and Gut-on-a-Chip Models for Assessing Oral Peptide Formulations.
    Gleeson JP; Zhang SY; Subelzu N; Ling J; Nissley B; Ong W; Nofsinger R; Kesisoglou F
    Mol Pharm; 2024 Aug; 21(8):3880-3888. PubMed ID: 38941485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Primary Cell-Based Organotypic Microtissues for Modeling Small Intestinal Drug Absorption.
    Ayehunie S; Landry T; Stevens Z; Armento A; Hayden P; Klausner M
    Pharm Res; 2018 Feb; 35(4):72. PubMed ID: 29476278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro-in vivo Pharmacokinetic correlation model for quality assurance of antiretroviral drugs.
    Rojas Gómez R; Restrepo Valencia P
    Colomb Med (Cali); 2015 Sep; 46(3):109-16. PubMed ID: 26600625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.
    Tubic-Grozdanis M; Bolger MB; Langguth P
    AAPS J; 2008; 10(1):213-26. PubMed ID: 18446522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of small intestinal permeability during normal human drug absorption.
    Levitt DG
    BMC Pharmacol Toxicol; 2013 Jun; 14():34. PubMed ID: 23800230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the First-Pass Metabolism of a Drug After Oral Intake Based on Structural Parameters and Physicochemical Properties.
    Hosseini MAH; Alizadeh AA; Shayanfar A
    Eur J Drug Metab Pharmacokinet; 2024 Jul; 49(4):449-465. PubMed ID: 38733548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improvement of Intestinal and Transmucosal Absorption of Peptide and Protein Drugs].
    Yamamoto A
    Yakugaku Zasshi; 2024; 144(7):697-714. PubMed ID: 38945845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models.
    Liu Y; Lawless M; Li M; Fairman K; Embry MR; Mitchell CA
    J Appl Toxicol; 2024 Aug; 44(8):1236-1245. PubMed ID: 38655841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions.
    Nicolas JM; Bouzom F; Hugues C; Ungell AL
    Biopharm Drug Dispos; 2017 Apr; 38(3):209-230. PubMed ID: 27976409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Food Effect on Oral Absorption of Efflux Transporter Substrate Drugs: Does Delayed Gastric Emptying Influence Drug Transport Kinetics?
    Sharma S; Prasad B
    Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Utilization of Tiny-TIM to Assess the Effect of Food on the Absorptions of Oral Drugs and Its Application on Biopharmaceutical Modeling.
    Liu J; Nagapudi K; Chiang PC
    J Pharm Sci; 2024 Jun; 113(6):1586-1596. PubMed ID: 38266915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo deposition of poorly soluble drugs.
    Lou Z; Mu C; Corpstein CD; Li T
    Adv Drug Deliv Rev; 2024 Aug; 211():115358. PubMed ID: 38851590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in cell-based in vitro models for predicting drug permeability across brain, intestinal, and pulmonary barriers.
    Eltanameli B; Piñeiro-Llanes J; Cristofoletti R
    Expert Opin Drug Metab Toxicol; 2024 Jun; 20(6):439-458. PubMed ID: 38850058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of Determination of Biopharmaceutical Properties for Development Candidate Selection.
    Yazdanian M
    Curr Protoc; 2023 Nov; 3(11):e926. PubMed ID: 37987149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the Biopharmacological Characteristics of Asperosaponin VI: Unveiling Dynamic Self-Assembly Phase Transitions in the Gastrointestinal Environment.
    Mo Y; Yang Y; Zeng J; Ma W; Guan Y; Guo J; Wu X; Liu D; Feng L; Jia X; Yang B
    Int J Nanomedicine; 2023; 18():7335-7358. PubMed ID: 38084126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of data base structure in a successful in vitro-in vivo correlation for pharmaceutical products.
    Roudier B; Davit B; Schütz H; Cardot JM
    AAPS J; 2015 Jan; 17(1):24-34. PubMed ID: 25387995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.